Population-Based Monitoring of an Urban HIV/AIDS Epidemic: Magnitude and Trends in the District of Columbia

JAMA: The Journal of the American Medical Association

Volumn 268, Issue 4, 1992, Pages 495-503

  Rosenberg, Pnilip S ^a   Levy, Martin E ^b   Brundage, John F ^c   Petersen, Lyle R ^d   Karon, John M ^d   Fears, Thomas R ^a   Gardner, Lytt I ^c   Gail, Mitchell H ^a   Goedert, James J ^a   Blattner, William A ^a   Ryan, Caitlin C ^e   Vermund, Sten H ^f   Biggar, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Viral Epidemiology Section Environmental Epidemiology Branch National Cancer Institute ^*  (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Center for HIV/AIDS   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE TRANSMISSION; DRUG USE; ETHNOLOGY; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; PREGNANCY; PRIORITY JOURNAL; SCREENING; UNITED STATES; URBAN POPULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; DISEASE OUTBREAKS; DISTRICT OF COLUMBIA; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMAN; INCIDENCE; MALE; MIDDLE AGE; MILITARY PERSONNEL; MODELS, STATISTICAL; NEGROID RACE; POPULATION SURVEILLANCE; PREGNANCY; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH;

EID: 0026741401     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03490040071028     Document Type: Article

References (45)

1. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States. JAMA. 1991;265:1704-1708.
2. Brundage JF, Burke PS, Gardner LI, et al. Tracking the spread of the HIV infection epidemic among young adults in the United States: results of the first four years of screening among civilian applicants for US military service. J Acquir Immune Defic Syndr. 1990;3:1168-1180.
3. Gardner LI, Brundage JR, Burke DS, McNeil JG, Visintine R, Miller RN. Evidence for spread of the human immunodeficiency virus epidemic into low prevalence areas of the United States. J Acquir Immune Defic Syndr. 1989;2:521-532.
4. St Louis ME, Rauch KJ, Petersen LR, et al. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. N Engl J Med. 1990;323:213-218.
5. District of Columbia Commission of Public Health. Dimension of the HIV/AIDS Epidemic in the District of Columbia: (Selected Sentinel Survey Sites). Washington, DC: District of Columbia Commission of Public Health; 1991.
6. Brookmeyer R, Gail MH. Minimum size of the acquired immunodeficiency syndrome epidemic in the United States. Lancet. 1986;2:1320-1322.
7. Brookmeyer R, Gail MH. A method for obtaining short-term projections and lower bounds on the size of the AIDS epidemic. J Am Stat Assoc. 1988; 83:301-308.
8. Gail MH, Brookmeyer R. Methods for projecting course of acquired immunodeficiency syndrome epidemic. J Nati Cancer Inst. 1988;80:900-911.
9. Brookmeyer R, Damiano A. Statistical methods for short term projections of AIDS incidence. Stat Med. 1989;8:23-34.
10. Day NE, Gore SM. Prediction of the number of new AIDS cases and the number of new persons infected with HIV up to 1992: the results of ‘back projection’ methods. In: Short-Term Prediction of HIV Infections and AIDS in England and Wales: Report of a Working Group. London, England: Her Majesty’s Stationery Office; 1989.
11. Isham V. Estimation of the incidence of HIV infection: the back projection method. In: Short-Term Prediction of HIV Infections and AIDS in England and Wales: Report of a Working Group. London, England: Her Majesty’s Stationery Office; 1989.
12. De Gruttola V, Lagakos SW. The value of AIDS incidence data in assessing the spread of HIV infection. Stat Med. 1989;8:35-43.
13. Taylor JMG. Models for the HIV infection and AIDS epidemic in the United States. Stat Med. 1989;8:45-58.
14. Rosenberg PS, Gail MH. Uncertainty in estimates of HIV prevalence derived by backcalculation. Ann Epidemiol. 1990;1:105-115.
15. Rosenberg PS, Gail MH. Backcalculation of flexible linear models of the human immunodeficiency virus infection curve. Appi Statistics. 1991;40:269-282.
16. Rosenberg PS, Biggar RJ, Goedert JJ, Gail MH. Backcalculation of the number with human immunodeficiency virus infection in the United States. Am J Epidemiol. 1991;131:276-285.
17. Centers for Disease Control. Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. MMWR. 1987;36(suppl 15):1-36.
18. Green TA, Karon JM, Nwanyanwa OC. Changes in AIDS incidence trends in the United States. J Acquir Immune Defic Syndr. 1992;5:547-555.
19. Centers for Disease Control. Estimates of HIV prevalence and projected AIDS cases: summary of a workshop, October 31-November 1, 1989. MMWR. 1990;39:110-119.
20. Karon JM, Dondero TJ, Curran JW. The projected incidence of AIDS and estimated prevalence of HIV infection in the United States. J Acquir Immune Defic Syndr. 1988;1:542-550.
21. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829-836.
22. Brookmeyer R, Goedert JJ. Censoring in an epidemic with an application to hemophilia-associated AIDS. Biometrics. 1989;45:325-335.
23. Biggar RJ, International Registry of Seroconverters. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS. 1990; 4:1059-1066.
24. Gail MH, Rosenberg PS, Goedert JJ. Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr. 1990;3:196-206.
25. Rosenberg PS, Gail MH, Schrager LK, et al. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. J Acquir Immune Defic Syndr. 1991;4:392-401.
26. Graham NMH, Zeger SL, Kuo V, et al. Zidovudine use in AIDS-free HIV-1—seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989. J Acquir Immune Defic Syndr. 1991;4:267-276.
27. Brookmeyer R, Liao J. Statistical modelling of the AIDS epidemic for forecasting health care needs. Biometrics. 1990;46:1151-1163.
28. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science. 1991;253:37-42.
29. Rosenberg PS, Gail MH, Carroll RJ. Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS. Stat Med. In press.
30. Selik RM, Buehler JW, Karon JM, Chamber-land ME, Berkelman RL. Impact of the 1987 revision of the case definition of acquired immune deficiency syndrome in the United States. J Acquir Immune Defic Syndr. 1990;3:73-82.
31. Pappaioanou M, George JR, Hannon WH, et al. HIV seroprevalence surveys of childbearing women: objectives, methods, and uses of the data. Public Health Rep. 1990;105:147-152.
32. St Louis ME, Olivo N, Critchley S, et al. Methods of surveillance for HIV infection at US sentinel hospitals. Public Health Rep. 1990;105:140-146.
33. Centers for Disease Control. HIV/AIDS Surveillance Report. Atlanta, Ga: Centers for Disease Control; November 1991:1-18.
34. District of Columbia Government Office of Policy and Program Evaluation. Indices: A Statistical Index to District of Columbia Services. 1991:80.
35. District of Columbia State Health Planning and Development Agency. Treatment Services: behavioral health. In: District of Columbia Comprehensive Health Plan: Section VIII. December 1989: VIII-b-12.
36. Hahn RA, Onorato IM, Jones TS, Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989;261: 2677-2684.
37. Goedert JJ, Biggar RJ, Melbye M, et al. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA. 1987;257:331-334.
38. Kingsley LA, Zhou SYJ, Bacellar H, et al. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989: a report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol. 1991;4:331-339.
39. San Francisco Department of Public Health. Young men’s survey, San Francisco, 1991. San Francisco Epidemiol Bull. 1991;7:31-33.
40. D’Angelo LJ, Getson PR, Luban NLC, Gayle HD. Human immunodeficiency virus infection in adolescents: can we predict who is at risk? Pediatrics. 1991;88:982-986.
41. D’Angelo LJ. A longitudinal study of HIV infection in urban adolescents. Presented at the Intersciences Conference on Antimicrobial Agents and Chemotherapy; October 1, 1991; Chicago, Ill.
42. Novick LF, Glebatis DM, Stricof RL, MacCubbin PA, Lessner L, Berns DS. Newborn seroprevalence study: methods and results. Am J Public Health. 1991;81(suppl):15-21.
43. Jack N, Cleghorn F, Murphy J, et al. Rising seroprevalence of HIV-1 and HTLV-1 in STD patients in Trinidad and Tobago. In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress; July 19-24,1992; Amsterdam, the Netherlands.
44. Agency for HIV/AIDS. Comprehensive HIV/ AIDS Plan: 1992-1996. Washington, DC: District of Columbia Commission of Public Health; July 1992.
45. Chu SY, Peterman TA, Doll LS, Buehler JW, Curran JW. AIDS in bisexual men in the United States: epidemiology and transmission to women. Am J Public Health. 1992;82:220.